๐ฐ Poster Presentations News
Page 4 - Poster Presentations News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Poster Presentations. Real-time updates on events, politics, business and more.
March 23, 2023
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2, HERKULES-3, FLAGSHP-1, and THUNDERBBOLT-1 trials ...
March 17, 2023
Theย National Consortium of Torture Treatment Programs (NCTTP)ย is a U.S. based network of programs which exists to advance the knowledge, technical capacities and resources devoted to the care of torture survivors living in the United States and acts collectively to prevent torture worldwide. The symposium is a full-day event and open to the public. The objective […]
January 31, 2023
ADELAIDE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO,), (Bionomics or the Company) a clinical-stage...
December 17, 2022
Greetings. We warmly welcome you to the CME/CPD accredited 10th World Digital Pathology & AI UCGCongress (DIGIPATH2023) scheduled on April 04-06, 2023 in
November 23, 2022
/PRNewswire/ -- Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical...
November 23, 2022
/PRNewswire/ -- GNS, the leader in the application of Causal AI and simulation and "Digital Twins" to discover new drugs, today announced two abstracts and two...
November 23, 2022
SOMERVILLE, Mass., Nov. 23, 2022 /PRNewswire/ -- GNS, the leader in the application of Causal AI and simulation and Digital Twins to discover ne...
November 4, 2022
Hundreds of researchers, students and guests attended the 24th University of Kentucky Cardiovascular Research Day at the Central Bank Center, an annual event that celebrates innovative research in cardiovascular health.
November 3, 2022
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First... | November 3, 2022
October 24, 2022
/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...